Detalles de la búsqueda
1.
Non-viral precision T cell receptor replacement for personalized cell therapy.
Nature
; 615(7953): 687-696, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36356599
2.
Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer.
Future Oncol
; 20(13): 851-862, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240151
3.
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer.
Oncologist
; 28(11): 978-985, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589215
4.
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.
J Immunother Cancer
; 12(2)2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423748
5.
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation.
J Thorac Oncol
; 19(3): 409-424, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37838086
6.
Lifileucel, an Autologous Tumor-infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors.
Cancer Discov
; 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38563600
7.
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Nat Commun
; 15(1): 2568, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531883
8.
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.
Cancer Immunol Res
; 12(3): 308-321, 2024 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108398
9.
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
Cancer Cell
; 42(2): 209-224.e9, 2024 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215748
10.
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab.
JAMA Netw Open
; 6(1): e2249591, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36602799
11.
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.
Nat Commun
; 14(1): 4238, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37454214
12.
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
J Clin Oncol
; 41(6): 1200-1212, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223558
13.
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers.
J Thorac Oncol
; 18(4): 463-475, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36494075
14.
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
medRxiv
; 2023 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37292751
15.
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study.
J Immunother Cancer
; 11(7)2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37487667
16.
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
J Immunother Cancer
; 11(11)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914383
17.
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC.
J Thorac Oncol
; 18(6): 731-743, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36775193
18.
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.
J Thorac Oncol
; 18(11): 1524-1537, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247843
19.
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.
Clin Cancer Res
; 29(13): 2540-2550, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097610
20.
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 29(21): 4408-4418, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432985